Our portfolio of in-house precision oncology solutions delivers rapid, reliable CGP insights in laboratories worldwide, backed by advanced proprietary bioinformatics.
Whether profiling tissue or liquid specimens, our goal is to empower clinicians and researchers with the solutions they need to elevate cancer care and advance research worldwide. We’ve channeled our precision oncology expertise into developing a suite of end-to-end offerings that deliver comprehensive and meaningful insights from low sample inputs.
Our products integrate optimized assay chemistry with an automated bioinformatics platform to quickly deliver reliable, actionable CGP results. PGDx elio products are available to labs worldwide to support our vision of making CGP testing readily available to all in order to elevate the standard of cancer care.
PGDx has developed a revolutionary portfolio of RUO and IVD kits powered by robust proprietary bioinformatics. By automating sample analysis and interpretation, PGDx is enabling the scalability of precision medicine with a fast, accurate, and comprehensive system.